78 results
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
and Corporate Governance Committee and three meetings of our Research and Development Committee. All of our then Directors attended a minimum of 75 … by Ultragenyx in November 2017. Prior leadership roles have included the head of global research and development at Merck Serono and SVP, Global Development
10-K
2023 FY
EX-10.30
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
that have issued or in the future issue therefrom, and in each case that are necessary or useful for the research, development, manufacture, use … to comment thereon.
b.ReproNovo, its Affiliates and their Sublicensees shall have the right to publicly disclose research, development and commercial
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
research and development programs, any future commercialization efforts or acquisitions of potential product candidates.
We depend heavily on the success … , or enrollment is slower than anticipated, in particular for our product candidates with rare disease indications, our research and development efforts could
8-K
EX-99.1
MREO
Mereo Biopharma Group Plc
27 Mar 24
Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
4:08pm
revenue received, subject to certain deductions.
Total research and development expenses decreased by $12.0 million, or 41%, from $29.5 million in 2022 …
Current assets:
Cash and cash equivalents
Prepaid expenses and other current assets
Research and development incentives receivables
Total current assets
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
7 Sep 23
Current report (foreign)
7:37am
30,
£’000
Six months endedJune 30,
£’000
Revenue
Cost of revenue
Research and development expenses
Administrative expenses
Other operating income … direct research and development expenses monitored by product candidate. The CODM makes decisions over resource allocation at an overall portfolio level
6-K
EX-99.3
fk531t4cuj70duage
7 Sep 23
Current report (foreign)
7:37am
6-K
EX-99.2
a8vwnib 46u
7 Sep 23
Current report (foreign)
7:37am
6-K
EX-99.2
at0 pk6pevblo
2 Nov 22
Current report (foreign)
4:17pm
6-K
EX-99.1
eqe tsc8ghdp5q4067nw
2 Nov 22
Current report (foreign)
4:17pm
6-K
EX-99.1
94cac64 zrmkfq0
22 Aug 22
Notifies Rubric of Certain Deficiencies in its Notice Purporting to Call a General Meeting of Shareholders
4:06pm
6-K
6fkklcdog ywrabc
9 May 22
Current report (foreign)
8:15am